Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7313867> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q7313867 subject Q13302180.
- Q7313867 subject Q1457057.
- Q7313867 subject Q8431759.
- Q7313867 abstract "Reolysin® (pelareorep; Wild-Type Reovirus; Serotype 3 Dearing; Oncolytics Biotech), is a proprietary formulation of the human reovirus (reovirus) being developed for the treatment of various cancers and cell proliferative disorders. Reolysin is classified as an oncolytic virus, a virus that preferentially lyses cancer cells. Clinical trials have demonstrated that Reolysin may have activity across a variety of cancer types when administered alone and in combination with other cancer therapies.In April 2015 the US FDA granted Orphan Drug Designation to Reolysin for malignant glioma.".
- Q7313867 wikiPageExternalLink www.oncolyticsbiotech.com.
- Q7313867 wikiPageWikiLink Q117636.
- Q7313867 wikiPageWikiLink Q13302180.
- Q7313867 wikiPageWikiLink Q13529450.
- Q7313867 wikiPageWikiLink Q1365309.
- Q7313867 wikiPageWikiLink Q1367466.
- Q7313867 wikiPageWikiLink Q1457057.
- Q7313867 wikiPageWikiLink Q1560099.
- Q7313867 wikiPageWikiLink Q1816041.
- Q7313867 wikiPageWikiLink Q204711.
- Q7313867 wikiPageWikiLink Q413299.
- Q7313867 wikiPageWikiLink Q415588.
- Q7313867 wikiPageWikiLink Q423762.
- Q7313867 wikiPageWikiLink Q424396.
- Q7313867 wikiPageWikiLink Q425227.
- Q7313867 wikiPageWikiLink Q5625184.
- Q7313867 wikiPageWikiLink Q600121.
- Q7313867 wikiPageWikiLink Q664846.
- Q7313867 wikiPageWikiLink Q681817.
- Q7313867 wikiPageWikiLink Q8431759.
- Q7313867 wikiPageWikiLink Q910576.
- Q7313867 comment "Reolysin® (pelareorep; Wild-Type Reovirus; Serotype 3 Dearing; Oncolytics Biotech), is a proprietary formulation of the human reovirus (reovirus) being developed for the treatment of various cancers and cell proliferative disorders. Reolysin is classified as an oncolytic virus, a virus that preferentially lyses cancer cells.".
- Q7313867 label "Reolysin".